Özlem Türeci
Founder bij BIONTECH SE
Vermogen: 84 M $ op 31-03-2024
Profiel
zlem Treci richtte BioNTech SE en Ganymed Pharmaceuticals AG op. Momenteel is zij voorzitter van Ci3 Management UG, voorzitter van de Association For Cancer Immunotherapy en Chief Medical Officer van BioNTech SE. In het verleden bekleedde zij de functie van Chief Executive & Medical Officer bij Ganymed Pharmaceuticals AG. Dr. Treci behaalde een bachelorgraad aan de Universitt des Saarlandes.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIONTECH SE
0.38% | 31-12-2023 | 913 247 ( 0.38% ) | 84 M $ | 31-03-2024 |
Actieve functies van Özlem Türeci
| Bedrijven | Functie | Begin |
|---|---|---|
| BIONTECH SE | Founder | 02-06-2008 |
| Association For Cancer Immunotherapy | President | - |
| Ci3 Management UG | Chairman | - |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
 Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Corporate Officer/Principal | - |
Eerdere bekende functies van Özlem Türeci
| Bedrijven | Functie | Einde |
|---|---|---|
Ganymed Pharmaceuticals AG
 Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Chief Executive Officer | - |
Opleiding van Özlem Türeci
| Universität des Saarlandes | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIONTECH SE | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Ganymed Pharmaceuticals AG
Ganymed Pharmaceuticals AG BiotechnologyHealth Technology Ganymed Pharmaceuticals AG develops antibodies for the treatment of solid cancers. It focuses on developing ideal monoclonal antibodies that include cancer-selective targets for maximal high-precision anticancer potency, as well as mitigates the threat of toxicity. The company was founded by Özlem Türeci, Dirk L. Sebastian, Christoph Huber and Ugur Sahin in 2001 and is headquartered in Mainz, Germany. | Health Technology |
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Medical/Nursing ServicesHealth Services Universitätsmedizin der Johannes Gutenberg-Universität Mainz KöR owns and operates medical institutions and clinics. It offers nursing and optimal patient care, diagnostic, care management, and other related healthcare services. The company is headquartered in Mainz, Germany. | Health Services |
| Association For Cancer Immunotherapy | |
| Ci3 Management UG |
